Preetish Ramasawmy

Preetish Ramasawmy is a Principal at AiiM Partners based in Oxford, England, where he leads investments in resource-efficient technology startups operating across digital infrastructure, energy, and global supply chains. Working alongside Founder Shally Shanker and General Partners Diana Lieberman and Maisie Ganzler, he is part of a venture capital team that was recently recognized on BlueMark's 2025 Practice Leaderboard. Prior to his current investment career, Ramasawmy earned a Ph.D. and conducted extensive scientific research, which included developing specialized artificial intelligence applications for cardiac MRI landmark detection. He additionally published a March 30, 2026, scientific study detailing the contrasting genetic effects in STAT4 for infectious diseases such as Leishmania guyanensis cutaneous leishmaniasis. Ramasawmy currently leverages this deep technical and scientific background to evaluate, fund, and scale advanced technologies that drive industrial resource efficiency within the venture capital ecosystem.